Additionally, the K-M curves presented that elevated IL4I1 expression had adverse outcomes in patients with ESCA, but a contrasting result was shown in ACC and CESC (Supplementary Figures S2H–J). This evidence concerns the gene IL4I1 and adrenal cortex carcinoma.